Goldman Sachs,-0.393217
William Blair,0.414039
email newsletter,0.560435
52-week low,-0.733835
strong buy rating,0.238906
ariad pharmaceuticals,-7.41839E-4
52-week high,-0.733835
small molecule drug,-0.460627
email address,0.448938
related companies,0.560435
report,0.0454319
InvestorPlace Broker Center,0.555736
average price target,-0.306622
high fees,-0.735674
Blair analyst Y.,0.414039
year-over-year basis,-0.240975
sell rating,0.328598
Zacks Investment Research,0.546233
personal trading style,0.598412
latest news,0.448938
target price,0.0454319
average price,-0.259085
consensus estimate,0.277594
shares,-0.215333
concise daily summary,0.448938
quarterly revenue,-0.240975
company,0.0821349
stock broker,0.245696
Ariad Pharmaceuticals Inc.,0.560435
consensus rating,0.407313
equities research analyst,0.328598
